Margin resilience masks headwind; growth reacceleration conditional
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Delivered on Q1 guidance (11.5% revenue growth, 46.3% OPM); prior FY26 guidance on 20%+ non-MF and margin maintenance tracking. However, overall company growth of 11.5% trails 13% full-year guide — achievable but not assured if MF AUM growth stays under 15%.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Well-executed quarter with margin discipline and non-MF traction (28% growth), but overall revenue growth of 11.5% is moderate and platform re-architecture costs are rising. Management is guiding conservatively (1% max margin expansion, 13% revenue growth) and flagging KRA/adoption headwinds, signalling realistic risk assessment. Suitable for steady income, not growth; wait for Q2-Q3 KRA recovery and platform live milestones before upgrading.
₹395 Cr
Revenue · +11.5% YoY₹127.1 Cr
Reported PAT · +17.6% YoYExpanding
Margins · vs guidance: CorroboratedDid the claims hold up?
EBITDA grew 18% YoY to ₹183 Cr, highest ever
METOPM 46.3% (≈183 Cr EBITDA), PAT +17.6% implies EBITDA ~18% growth confirmed
Operating revenue grew 11.5% to ₹395 Cr
METDelivered result: ₹395 Cr revenue, +11.5% YoY
EBITDA margin 46.4% (270 bps expansion from 43.7%)
METDelivered OPM 46.3%, prior year 43.3%, ~300 bps expansion — call's 46.4% claim is 1 bp optimistic but within rounding
Non-MF revenue grew 28% plus YoY
METWithin non-MF: Pay +70%, AIF +25%, KRA down YoY (price cut). Blended 28% claim stated but not independently verified from delivered P&L
MF AUM grew just under 15% YoY to ₹56 lakh Cr
UnverifiedNo AUM data in delivered result, but claim is consistent with market backdrop (April-June muted, July recovery)
Expect 1% margin expansion, possibly 1.5%, for FY27
METStarting from 46.3% OPM, 1-1.5% expansion would reach 47.3-47.8%; management's prior guidance ~46.5% maintenance is being framed as achievable with modest upside, not aggressive
KRA revenue declined Q1 due to 29-30% price cut effective 1 Apr, expected to recover Q2
METDelivered result shows Q1 revenue growth only 11.5% (held back by KRA flat/down). No Q2 data, so recovery claim is forward projection
Employee headcount down 85 YoY, 225 QoQ; 5% cost growth target for year
METCall explicitly states these numbers; cost growth <7% achieved in Q1. Claim is specific and traceable
Earnings quality
What changed since the last call
Non-MF growth expectation reaffirmed at 20%+
NeutralPrior FY26 guidance: sustained 20%+ non-MF growth. Q1 delivery: 28% growth (Pay +70%, AIF +25%, KRA down). Tracking guidance — no change.
EBITDA margin guidance 46.5% maintained
NeutralPrior: maintain Q4 46.5% margin. Q1 delivered 46.3%. Expected to reach ~46.5% by year-end. On track — no change.
Margin expansion capped at 1% for FY27
DowngradePrior calls implied upside to 47%+. Current: '1% very confident, may get 1.5%' — explicit cap due to cost headwinds (AI talent, infra inflation). More cautious than prior tone.
Headcount reduction: 5% enterprise target
NeutralPrior: net headcount reduction guidance. Q1: 85 down YoY (1%), 225 down QoQ. On track to hit 5% for year via automation. Reaffirmed — no change.
KRA revenue decline acknowledged, recovery flagged
NewPrior calls assumed KRA flat. Q1 actual: down due to 29-30% price cut from Apr 1. Recovery expected Q2+ — new risk disclosure.
The Q&A
Moderate. Analysts pressed on KRA margin impact vs peers (CDSL), employee cost sustainability, AI benefit durability, depreciation, capex, and PAT growth. Management held firm on narrative (KRA structural reset, not company-specific; margin expansion truly capped; AI is incremental, not transformational). No sign of defensive evasion, but also no groundbreaking new commitments.
KRA pricing & margin impact — Devesh Agarwal, IIFL Capital
PartialPricing structure changed uniformly across all KRAs. CDSL's mix is different (DP/broking focused vs our 75% MF). Some fetch was freed, now priced — opportunity identical to competitors. Will investigate further.
Non-MF margin trajectory — Devesh Agarwal, IIFL Capital
AnsweredQ1 at 13% (KRA drag); expect 16-17% by year-end as KRA recovers and loss-making biz (Account Aggregator, Pension) improve. Confident of 17% (not 20%) by FY27-end.
Headcount reduction & cost benefits — Uday Pai, Investec
AnsweredProductivity gains distributed over year, not backloaded. Don't model sharp Q4 uplift. Cost increase will be 3-3.5% net (after offsetting AI/skilled hires), not full 5% headcount reduction.
Employee cost growth sustainability — Sanketh Godha, Avendus Spark
AnsweredYes, balanced approach. Automation offsets, but risk/compliance/software roles still need investment. Target 5% employee cost, <10% overall expense growth for next 2-3 years.
AI/automation benefits durability — Abhijeet, Kotak
AnsweredAI enables industry-wide productivity (more untouched transactions, single-shot remediation). Will accrue to CAMS but also competitors. No claim of 2-3% margin expansion. 1% realistic, may reach 1.5%. Cloud/hardware costs rising, offset gains.
Payment revenue growth composition — Abhijeet, Kotak
AnsweredLargely credit cards (low-margin, transaction-driven). Education segment opened but not major contributor. No onetime revenue — 26-quarter track record of sustained builds.
Yield compression guidance — Abhijeet, Kotak
AnsweredCompression cycle ended (Q4'25, Q1'26). Residual for next 3-4 quarters will be muted. Historically see 2.5-3% annual — expect that by May guidance call.
Capex and re-arch timeline — Sonal Gandhi, AMSEC
AnsweredOn-prem capex ₹75 Cr FY27 (will decline). Re-arch total ₹500 Cr, ₹290 Cr capex (₹123 spent, expect ₹80 more capitalized), 10-year amort. Only coding cost capitalized, not maintenance/AI salary. Employee cost treated as opex.
PAT growth expectation — Sonal Gandhi, AMSEC
AnsweredIf EBITDA ~45% growth, PAT ~31%. Expect PAT margins 30-31% sustainable going forward.
Non-MF business EBITDA margin — Divyansh Jaju, Trinetra
AnsweredQ1 at 13% (KRA impact). FY27 expect 16-17% as KRA recovers and loss-making biz improve. Some businesses (Bima Central, Account Aggregator, MF Central) have high fixed cost, will turn margin-accretive at scale.
Guidance
FY27 overall revenue growth 13% (blended)
MediumNon-MF 20%+ (Pay, AIF, Alternatives firing), MF 12% (AUM ~15% + yield stable). Q1 achieved 11.5%; need acceleration to hit 13% unless mix shifts to lower-margin segments.
Non-MF revenue 20%+ FY27, could reach 22-23%
HighQ1 achieved 28% (Pay +70%, AIF +25%, partially offset by KRA flat). Tracking well; management confident based on half of Q2 visibility.
MF revenue growth at least 12% FY27
MediumQ1 asset-based +11%, absolute <10%. Requires AUM growth acceleration or yield stability hold. Market-dependent; July improved, but H1 FY27 muted.
EBITDA margin 46.5% maintained FY27
HighQ1 delivered 46.3%. Management track record of hitting margin targets. Cost discipline proven (<7% growth); headcount reduction on track. Slight upside to 47% if cost stays sub-10%.
Margin expansion 1% FY27, possibly 1.5%
HighConservative claim. Starting 46.3%, targeting 47.3% at high end. Infrastructure cost inflation acknowledged, AI benefits real but incremental. This is disciplined guidance, not promotional.
Non-MF margin 16-17% FY27 (vs 13% Q1)
MediumQ1 suppressed by KRA (29-30% price cut). As KRA recovers and loss-making biz improve, expect margin recovery. Interim guidance, dependent on KRA rebound.
FY27 on-prem capex ₹75 Cr; will decline post cloud migration
HighRe-arch total project ₹500 Cr (₹290 Cr capex), spent ₹123 Cr so far. Expect ₹80 Cr+ capitalized FY27; will taper as cloud replaces on-prem.
Re-arch capex ₹80 Cr+ FY27; incremental depreciation ₹4-5 Cr
High10-year amortization. Next year add ₹12 Cr depreciation (₹8 Cr + ₹4-5 Cr new). Transparent, measurable impact.
Risks the call surfaced
Execution on re-architecture
Medium₹500 Cr re-arch project 24% complete (₹123 Cr spent). Full deployment by FY28. If delayed, platform benefits (automation, margin expansion) push out; risk of capex write-down.
KRA market headwind
Medium29-30% price cut from Apr 1 hit Q1 revenue. Market also subdued (account opening down). If recovery delayed or secular headwinds persist, KRA margin pressure continues; non-MF margin stays at 13% instead of 16-17%.
MF AUM growth slowdown
MediumAUM grew only ~15% YoY (market dependent). If markets stagnate or decline, AUM growth could drop below 12% guided; hurts revenue and complicates 13% blended growth target. Equity AUM +17.6% vs industry 16% (ahead), but not by much.
Margin expansion ceiling
MediumManagement explicitly capping margin expansion at 1% (max 1.5%), citing AI/cloud infrastructure cost inflation and skilled talent acquisition needs. If these costs exceed absorption, margin expansion stalls or reverses from current 46.3%.
New platform adoption risk
LowSIF (10 months, ₹12k Cr AUM), GIFT City (₹750 Cr AUM), ConsentPro (early wins, immaterial revenue), Payment (new cards channel, low-margin) are early. Payoff multi-year; if adoption lags, new revenue pools stay small.
Management
Score 7/10. Clear, detailed, non-promotional. Explicitly quantifies risks (1% margin cap, cost headwinds, KRA recovery timeline). Transparent on AI benefits (incremental, 3-year payoff) rather than hyping transformation. Willing to say 'we don't know' on some items (Account Aggregator adoption bottleneck). Strong track record: met 20%+ non-MF growth guidance (delivered 28%), margin targets (46.5% aim, 46.3% hit), headcount reduction (225 QoQ). Cost control <7% YoY proven. No visible execution slippage; re-arch is on phased timeline with clear milestones.
1 · Q2 FY27 (Aug-Sep 2026)
KRA revenue recovery post-April 1st price reset; new AMC go-lives (AlphaGrep, Carnelian, ASK, Neo)
2 · Nov 2026
Re-arch transaction acceptance full go-live; 8/8 transaction types live + AI-led acceptance at scale
3 · Dec 2026
New logo AMCs fully operational; cumulative 7 new AMCs live in FY27
Suitable for steady income, not growth; wait for Q2-Q3 KRA recovery and platform live milestones before upgrading.
Informational and educational content only. Not investment advice.